The S2TOP-BLEED score which estimates the 3-year risk of major bleeding in patients with a history of ischemic stroke or transient ischemic attack treated with antiplatelet agents.
All articles by Shannon Aymes, MD
A 3-year major bleeding risk can be determined by using the S2TOP-BLEED score in patients with ischemic stroke using antiplatelet agents.
Differences in incidence as opposed to case fatality is the main contributing factor to racial disparities in stroke mortality.
Patients who were categorized as class II and III obesity had higher risks of overall early postoperative complications than patients with normal BMIs.
Rate vs rhythm control for postoperative atrial fibrillation yieled no statistically significant differences in adverse events or death.
According to results from the FIRE & ICE clinical trial, cyroballon ablation was noninferior in safety and efficacy to radiofrequency ablation in patients with refractory parosysmal atrial fibrillation.
Mobile health initiative, Stepathlon, improved physical activity and weight as well as sitting duration.
While fewer than 2% of severe hypercholesterolemia cases can be linked to familial hypercholesterolemia mutations, the latter does increase risk for coronary artery disease.
Exercise’s potential positive effects on cardiovascular disease and heart failure may be possible regardless of frequency and time of initiation.